YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - DIL
BSE: 506414NSE: ISIN: INE225B01013

12th-Apr-2017 13:13Source: BSE

DIL - Regulation 13(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations')

April 12, 2017 Corporate Relations The Bombay Stock Exchange Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai 400 001 Dear Sir, Sub: Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations'') Ref: Company Code No 506414 With reference to the above, please find herewith Quarterly Statement of Investor Complaints for the quarter ended March 31, 2017. Kindly take the above on records and oblige.

Follow us on
Available On